AstraZeneca said a Covid-19 vaccine it is developing with Oxford university could still be ready by the end of 2020, despite pausing trials after a participant developed an unexplained illness
LONDON—AstraZeneca PLC’s chief executive said a Covid-19 vaccine it is developing with the University of Oxford could still be ready by the end of the year, despite the company pausing late-stage trials after a participant in the U.
K. developed an unexplained illness. Chief Executive Pascal Soriot said the progress of a safety review into the trial subject will determine the timetable for vaccine progress. He said, though, that he still expects a set of data from the trials that can be presented to regulators for approval...
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID vaccine candidate developed by Oxford University and AstraZeneca put on hold after 'unexplained illness'Drug giant AstraZeneca is reviewing the event that caused the illness during Phase 3 of Oxford's COVID-19 vaccine trials. The interruption represents the first major hiccup in what has been a smooth path in the rapid vaccine effort spanning the globe.
Read more »
Oxford vaccine trial on hold because of safety issueJUST IN: Clinical trials for Oxford's COVID-19 vaccine have been put on hold due to a “potentially unexplained illness in one of the trials,” AstraZeneca says Tuesday.
Read more »
Trump says COVID vaccine could come in 'weeks' despite AstraZeneca setback'This is a vaccine that we're going to have very soon,' the president said. 'By the end of the year. But much sooner than that perhaps.'
Read more »
Oxford vaccine trial on hold because of potential safety issueThe 'routine action' was taken to allow an independent review of safety data, drugmaker AstraZeneca said.
Read more »
AstraZeneca Pauses COVID-19 Vaccine Trial Due To Volunteer's IllnessNPR's Noel King talks to Paul Offit of the Vaccine Education Center at Children's Hospital of Philadelphia, about the coronavirus vaccine trial developed by AstraZeneca and the University of Oxford.
Read more »
COVID-19 vaccine candidate from Oxford University and AstraZeneca on hold after 'unexplained illness'The interruption in testing the Oxford vaccine candidate is the first major hiccup in a remarkably smooth effort to develop a coronavirus vaccine.
Read more »